IP Issues in the Therapeutic Antibody Industry
关键词: ip issues therapeutic antibody industry来源: 互联网
The following section is related to IP issues in the therapeutic Antibody industry. A rough overview over protected enabling techniques and compounds is provided, in order to facilitate the entry into freedom to operate studies. Furthermore, some general information about specific issues is provided, and the stories of some historic lawsuits fought between Antibody companies in the past are being told.
推荐方法
- RB蛋白相互作用相关因子(RIZl)
- 胸腺中T细胞的选择
- 初始B细胞的特性及其激活途径
- 带有死亡结构域的Fas结合蛋白
- 免疫细胞膜分子(一):主要组织相容性抗原-- MHC基因结构
- 抗生素(antibiotics)
- Support Vector Machine-Based Prediction of MHC-Binding Peptides
- Purification of Immature CD4+CD8+ Thymocytes by Panning with Anti-CD8 Antibody
- Immuno-Laser Capture Microdissection of Rat Brain Neurons for Real Time Quantitative PCR
- Effects of Selective Immunotoxic Lesions on Learning and Memory